Short and Long-Term Effectiveness of Ustekinumab in Patients with Crohn's Disease: Real-World Data from a German IBD Cohort.

Kubesch, Alica; Rueter, Laurenz; Farrag, Karima; Krause, Thomas; Stienecker, Klaus; Hausmann, Johannes; Filmann, Natalie; Dignass, Axel; Stein, Jürgen; Blumenstein, Irina

Kubesch, Alica; Rueter, Laurenz; Farrag, Karima; Krause, Thomas; Stienecker, Klaus; Hausmann, Johannes; Filmann, Natalie; Dignass, Axel; Stein, Jürgen; Blumenstein, Irina.

Afiliación

Kubesch A; Department of Medicine 1, Goethe University Hospital, 60590 Frankfurt a.M., Germany.
Rueter L; Department of Medicine 1, Goethe University Hospital, 60590 Frankfurt a.M., Germany.
Farrag K; Interdisciplinary Crohn-Colitis Centre Rhein-Main, 60594 Frankfurt a. M., Germany.
Krause T; Gastroenterological practice, 34117 Kassel, Germany.
Stienecker K; Gastroenterological practice, 36039 Fulda, Germany.
Hausmann J; Department of Medicine 1, Goethe University Hospital, 60590 Frankfurt a.M., Germany.
Filmann N; Institute of Biostatistics and Mathematical Modeling, University Hospital, Goethe University, 60590 Frankfurt a. M., Germany.
Dignass A; Department of Internal Medicine 1, Agaplesion Markus Krankenhaus, 60431 Frankfurt a. M., Germany.
Stein J; Interdisciplinary Crohn-Colitis Centre Rhein-Main, 60594 Frankfurt a. M., Germany.
Blumenstein I; Department of Medicine 1, Goethe University Hospital, 60590 Frankfurt a.M., Germany.

J Clin Med ; 8(12)2019 Dec 04.

Article en En | MEDLINE | ID: mdl-31817134

Palabras clave

Crohn's disease; IBD; biologics; efficacy; real-world data; ustekinumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: J Clin Med Año: 2019 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google